These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2081477)

  • 1. Metabolism of exogenous S-adenosyl-L-methionine in patients with liver disease.
    Kaye GL; Blake JC; Burroughs AK
    Drugs; 1990; 40 Suppl 3():124-8. PubMed ID: 2081477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part I. Biochemical implications.
    Mato JM; Corrales F; Martin-Duce A; Ortiz P; Pajares MA; Cabrero C
    Drugs; 1990; 40 Suppl 3():58-64. PubMed ID: 2081481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of S-adenosyl-L-methionine on liver damage in experimental obstructive jaundice.
    Tsai SM; Lee KT; Tsai LY
    Kaohsiung J Med Sci; 2001 Sep; 17(9):455-60. PubMed ID: 11842648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [S-adenosyl-L-methionine (SAMe) and its use in hepatology].
    Frezza M; Terpin MM; Peri A
    Minerva Gastroenterol Dietol; 1992; 38(3):145-51. PubMed ID: 1299337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal absorption of S-adenosyl-L-methionine.
    Stramentinoli G; Gualano M; Galli-Kienle M
    J Pharmacol Exp Ther; 1979 Jun; 209(3):323-6. PubMed ID: 439007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease.
    Chawla RK; Bonkovsky HL; Galambos JT
    Drugs; 1990; 40 Suppl 3():98-110. PubMed ID: 2081485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part II. Clinical consequences and potential for pharmacological intervention in cirrhosis.
    Pisi E; Marchesini G
    Drugs; 1990; 40 Suppl 3():65-72. PubMed ID: 2081482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of S-adenosyl-L-methionine in liver health and injury.
    Mato JM; Lu SC
    Hepatology; 2007 May; 45(5):1306-12. PubMed ID: 17464973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule.
    Bottiglieri T
    Am J Clin Nutr; 2002 Nov; 76(5):1151S-7S. PubMed ID: 12418493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-adenosyl-L-methionine: its role in the treatment of liver disorders.
    Lieber CS
    Am J Clin Nutr; 2002 Nov; 76(5):1183S-7S. PubMed ID: 12418503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility.
    Anstee QM; Day CP
    J Hepatol; 2012 Nov; 57(5):1097-109. PubMed ID: 22659519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for S-adenosylmethionine independent catabolism of methionine in the rat.
    Case GL; Benevanga
    J Nutr; 1976 Dec; 106(12):1721-36. PubMed ID: 993853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of S-adenosyl-L-methionine in the treatment of liver diseases.
    Lieber CS
    J Hepatol; 1999 Jun; 30(6):1155-9. PubMed ID: 10406198
    [No Abstract]   [Full Text] [Related]  

  • 14. S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism.
    Friedel HA; Goa KL; Benfield P
    Drugs; 1989 Sep; 38(3):389-416. PubMed ID: 2680435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: S-adenosyl-L-methionine--a new therapeutic agent in liver disease?
    Osman E; Owen JS; Burroughs AK
    Aliment Pharmacol Ther; 1993 Feb; 7(1):21-8. PubMed ID: 8439634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropharmacology of S-adenosyl-L-methionine.
    Baldessarini RJ
    Am J Med; 1987 Nov; 83(5A):95-103. PubMed ID: 3318448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine.
    Finkelstein JD
    Clin Chem Lab Med; 2007; 45(12):1694-9. PubMed ID: 17963455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease.
    Vendemiale G; Altomare E; Trizio T; Le Grazie C; Di Padova C; Salerno MT; Carrieri V; Albano O
    Scand J Gastroenterol; 1989 May; 24(4):407-15. PubMed ID: 2781235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of a deficiency in S-adenosyl-L-methionine synthesis in the pathogenesis of liver injury.
    Martínez-Chantar ML; García-Trevijano ER; Latasa MU; Pérez-Mato I; Sánchez del Pino MM; Corrales FJ; Avila MA; Mato JM
    Am J Clin Nutr; 2002 Nov; 76(5):1177S-82S. PubMed ID: 12418501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
    Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
    Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.